Salvage cytoreductive surgery for recurrent endometrial cancer

Gynecologic Oncology
Robert E BristowDeborah K Armstrong

Abstract

To determine the survival impact of salvage cytoreductive surgery, and other prognostic variables, among patients with recurrent endometrial cancer. All patients diagnosed with endometrial cancer recurrence between 7/1/97 and 6/30/05 were retrospectively identified from the tumor registry database. Demographic, pathological, and clinical data were abstracted from the medical record. Survival estimates were calculated using the Kaplan and Meier method. Univariate and multivariate regression analyses were used to identify characteristics associated with overall survival from time of recurrence. Sixty-one patients were identified with endometrial cancer recurrence a median of 18.5 months after initial diagnosis. Median age at recurrence was 63 years, and the median post-recurrence follow-up time was 22.0 months. Thirty-five patients underwent salvage cytoreductive surgery and had a median survival time of 28.0 months, compared to 13.0 months for patients treated non-surgically (P < 0.0001). Complete cytoreduction (no gross residual) was achieved in 23/35 surgical patients (65.7%). The median EBL was 350 cc and 28.6% of patients received blood products. There were no peri-operative deaths; however, 31.4% of patients experienced min...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·B W CornG E Hanks
Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P G RoseR E Hunter
Oct 1, 1988·International Journal of Radiation Oncology, Biology, Physics·W J CurranJ Fanning
Dec 1, 1993·Gynecologic Oncology·T W BurkeD M Gershenson
Feb 1, 1994·Gynecologic Oncology·B A GoffL W Rice
Nov 5, 1997·Gynecologic Oncology·D S ChiR R Barakat
Sep 30, 1999·Gynecologic Oncology·R R BarakatJ P Curtin
Mar 31, 2000·Gynecologic Oncology·J WylieA Fyles
Oct 9, 2002·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·A AyhanT Kucukali
May 31, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Scott WadlerGary Goldberg
Dec 17, 2003·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·R E BristowF J Montz
Dec 24, 2003·Cancer·Elio CampagnuttaCarlo Scarabelli
Feb 24, 2006·Gynecologic Oncology·Christopher S AwtreyDennis S Chi

❮ Previous
Next ❯

Citations

Jun 7, 2014·Gynecologic Oncology·William M BurkeUNKNOWN Society of Gynecologic Oncology Clinical Practice Committee
Oct 29, 2014·Case Reports in Obstetrics and Gynecology·Rita LuzIsabel Matos
Jul 28, 2010·The Oncologist·J Alejandro Rauh-Hain, Marcela G Del Carmen
Apr 24, 2012·ISRN Oncology·Ettie Piura, Benjamin Piura
Mar 24, 2009·Archives of Gynecology and Obstetrics·Benjamin PiuraRuthy Shaco-Levy
Mar 27, 2012·Lancet·Jason D WrightThomas J Herzog
Jun 16, 2015·Gynecologic Oncology Reports·Hordur Alexander HardarsonKirsten M Jochumsen
Apr 29, 2008·Clinical Oncology : a Journal of the Royal College of Radiologists·C M Holland
Mar 18, 2015·Annals of Surgical Oncology·Andrea PapadiaFrancesco Raspagliesi
May 4, 2010·Gynecologic Oncology·Joyce N BarlinRobert E Bristow
Mar 25, 2017·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Lavinia DomeniciChristina Fotopoulou
May 12, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Haider MahdiMehdi Moselmi-Kebria
Aug 11, 2018·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Haruko IwaseTakashi Onda
Sep 24, 2015·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Taner TuranGokhan Tulunay
May 14, 2014·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Huei-Jean HuangChyong-Huey Lai
May 2, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·F H van WijkHelena C van Doorn
Dec 4, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Francesco LeggeFrancesco Fanfani
Jul 12, 2016·American Journal of Clinical Oncology·Mohamed A ElshaikhUNKNOWN Expert Panel on Radiation Oncology–Gynecology:
Dec 21, 2010·Expert Review of Anticancer Therapy·Cathrine Holland
May 9, 2019·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Anna GermanovaDavid Cibula
May 18, 2019·International Journal of Clinical Oncology·Ayumi ShikamaToyomi Satoh
Aug 23, 2020·International Journal of Environmental Research and Public Health·Hui-Hua ChenSheng-Mou Hsiao
Feb 1, 2021·Gynecologic Oncology·Chad A HamiltonWilliam M Burke
Sep 14, 2019·Gynecologic Oncology Reports·Lindsey A McAlarnenMatthew M Harkenrider
Jun 7, 2021·Gynecologic Oncology·Lea A MoukarzelJennifer J Mueller

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.